ResMed insider plans minor 50-share sale per Form 144 filing

Rhea-AI Filing Summary

ResMed Inc. (RMD) – Form 144 filing: Insider Michael Rider has notified the SEC of his intent to sell up to 50 common shares through Fidelity Brokerage on or about 01 Aug 2025 on the NYSE. The shares carry an estimated market value of $14,095 and originate from restricted-stock vesting on 11 Nov 2021 that was received as compensation.

The filing also discloses earlier open-market sales by Rider in the last three months: 41 shares on 02 Jun 2025 for $9,994.98 and 66 shares on 01 Jul 2025 for $16,961.34. In total, Rider has sold or proposes to sell 157 shares in the period, compared with the company’s 146,627,399 shares outstanding, resulting in a de-minimis ownership impact (<0.001%). No other material terms, lock-ups, or 10b5-1 plan details are provided in the notice.

Insights

Securities Analyst

TL;DR: Micro-sized insider sale; negligible ownership impact, neutral signal.

The Form 144 covers just 50 shares—far below any threshold that typically moves liquidity or sentiment. Even aggregated with the prior two sales, the total value is under $41k and represents an immaterial fraction of the 146.6 million shares outstanding. No adverse operational information is signalled, and the shares stem from routine equity compensation. Consequently, I view the disclosure as non-impactful for valuation or governance risk.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	50	14095.00	146627399	08/01/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/11/2021	Restricted Stock Vesting	Issuer			50	11/11/2021	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Michael Rider 9001 Spectrum Center Blvd. San Diego CA 92123	Common	06/02/2025	41	9994.98
Michael Rider 9001 Spectrum Center Blvd. San Diego CA 92123	Common	07/01/2025	66	16961.34

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many ResMed (RMD) shares does Michael Rider plan to sell?

The Form 144 states he intends to sell 50 common shares.

What is the approximate market value of the proposed sale?

The filing lists an aggregate market value of $14,095 for the 50 shares.

When is the planned sale date for the shares?

The approximate sale date provided is 01 August 2025.

How many shares has Michael Rider sold in the past three months?

He previously sold 41 shares on 02 Jun 2025 and 66 shares on 01 Jul 2025, totaling 107 shares.

What percentage of ResMed’s shares outstanding do these sales represent?

Even including past sales, the 157 shares amount to under 0.001% of the 146.6 million shares outstanding.